Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 USD | +2.11% | -11.77% | +59.78% |
09/05 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.78% | 45Cr | |
+4.73% | 11TCr | |
+11.58% | 11TCr | |
+0.26% | 2.23TCr | |
-11.84% | 2.21TCr | |
-7.82% | 1.87TCr | |
-38.36% | 1.76TCr | |
-9.42% | 1.69TCr | |
+4.96% | 1.38TCr | |
+37.12% | 1.25TCr |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Transcript : Larimar Therapeutics, Inc. - Special Call